Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.

By U. Leiter, R. Stadler, C. Mauch, W. Hohenberger, N. Brockmeyer, C. Berking, C. Sunderkötter, M. Kaatz, K. Schulte, P. Lehmann and 8 more. The Lancet Oncology, 2016

639 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology, Ophthalmology

View Paper: https://www.semanticscholar.org/paper/8db70f9a3ae08c6b6069e84c699362c08f5151e6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. O. Michielin
2. A. V. Akkooi
3. R. Dummer
4. P. Ascierto
5. U. Keilholz

Citations in the corpus

• Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. (2019, background): “Both studies reported no impact on survival for early CLND compared to nodal observation with periodic US of the SN-positive basin [37, 38].”